GL1X · GenesisL1 explorer

MolNFT v1 · #119118 · protein

Structure and function based design of plasmodium-selective proteasome inhibitors

5FMG · Proteasome subunit alpha, putative: “Structure and function based design of plasmodium-selective proteasome inhibitors”. Electron microscopy, 1 ligand (7F1), 20 pockets (best druggability 0.77). MolNFT v1 #119118 on GenesisL1: 3D…

PDB
5FMG
Type
protein
Length
5,716 residues
Chains
28
Method
electron microscopy
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Proteasome subunit alpha, putative; Proteasome subunit alpha type 2, putative; Proteasome…
EC
3.4.25.1
UniProt
Q8IAR3, C6KST3, Q8IDG3, Q8IDG2, Q8IBI3, Q8IK90, O77396, Q8I0U7, Q8I6T3, Q8I261, Q8IKC9, Q8IJT1, C0H4E8, Q7K6A9
Ligands
7F1
Pockets
20 · best druggability 0.77

Structure

electron microscopy · 14 distinct chains · 34% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, OProteasome subunit alpha, putative (EC 3.4.25.1)protein21933% helix, 13% strandQ8IAR3
B, PProteasome subunit alpha type 2, putative (EC 3.4.25.1)protein21237% helix, 13% strandC6KST3
C, QProteasome subunit alpha type (EC 3.4.25.1)protein22040% helix, 15% strandQ8IDG3
D, RProteasome subunit alpha type (EC 3.4.25.1)protein21537% helix, 24% strandQ8IDG2
E, SProteasome subunit alpha type (EC 3.4.25.1)protein21734% helix, 17% strandQ8IBI3
F, TProteosome subunit alpha type 1, putativeprotein21934% helix, 16% strandQ8IK90
G, UProteasome component C8, putativeprotein21935% helix, 17% strandO77396
H, VProteasome, putative (EC 3.4.25.1)protein19130% helix, 24% strandQ8I0U7
I, WProteasome subunit beta type (EC 3.4.25.1)protein18633% helix, 28% strandQ8I6T3
J, XBETA3 proteasome subunit, putative (EC 3.4.25.1)protein19132% helix, 24% strandQ8I261
K, YProteasome subunit beta type (EC 3.4.25.1)protein19429% helix, 24% strandQ8IKC9
L, ZProteasome subunit beta type (EC 3.4.25.1)protein18932% helix, 24% strandQ8IJT1
M, aProteasome subunit beta type (EC 3.4.25.1)protein19931% helix, 22% strandC0H4E8
N, bProteasome subunit beta type (EC 3.4.25.1)protein18733% helix, 32% strandQ7K6A9

Ligands and binding sites

  • 7F1 · (2S)-N-[(E,2S)-1-(1H-indol-3-yl)-4-methylsulfonyl-but-3-en-2-yl]-2-[[(2S)-3-(1H-indol-3-yl)-2-(2-morpholin-4-ylethanoylamino)propanoyl]amino]-4-methyl-pentanamide · ligand · 2 copies · chains I, J, W, X

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 20 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18970.770.8094empty
210170.770.79119empty
311480.750.78116empty
48950.740.7893empty
511630.740.77123empty

Interfaces

70 interfaces between chains.

  • A–G · 1010 Ų buried · 5 hydrogen bonds · protein-protein
  • Q–R · 1005 Ų buried · 12 hydrogen bonds · protein-protein
  • O–U · 1004 Ų buried · 5 hydrogen bonds · protein-protein
  • C–D · 1000 Ų buried · 12 hydrogen bonds · protein-protein
  • F–G · 967 Ų buried · 12 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 8 disulfide, 2 covalent (disulfide, covalent ligand).

Compared structures

  • 5FMG · Structure and function based design of Plasmodium-selective proteasome inhibitors · the same entry in another collection · chain T against T, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.